Sign in

CIK 0000886163

  • Large accelerated filer

LIGAND PHARMACEUTICALS INC

Sign in to watch
Tickers
LGND LGNDZ LGNXZ LGNYZ LGNZZ
Exchange
Nasdaq, OTC
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
770160744
Phone
+1 858-550-7500
Business address
7111 FAIRWAY DRIVE, SUITE 302, PALM BEACH GARDENS, FL, 33418
Former names
LIGAND PHARMACEUTICALS

Securities

  • LGND Common Stock Nasdaq
  • LGNDZ Common stock OTC
  • LGNXZ Common stock OTC
  • LGNYZ Common stock OTC
  • LGNZZ Common stock OTC
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$7,384,247
in 9 filings, $4.7M under 10b5-1 plans

Net −$7,384,247. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Reading 100 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2013-11-26 BVF PARTNERS L P/IL 10% owner Sale −34,917 $57.57 $2.0M 128,581
2013-11-25 KOZARICH JOHN W Director Exercise or conversion +613 $7.40 $5K 42,339
2013-11-25 KOZARICH JOHN W Director Exercise or conversion +630 $6.82 $4K 42,969
2013-11-25 KOZARICH JOHN W Director Exercise or conversion · Non-Qualified Stock Option (right to buy) −630 0
2013-11-25 KOZARICH JOHN W Director Exercise or conversion · Non-Qualified Stock Option (right to buy) −613 0
2013-11-20 LAMATTINA JOHN L Director Gift −3,800 21,356
2013-11-18 KOZARICH JOHN W Director Exercise or conversion +460 $14.86 $7K 41,726
2013-11-18 KOZARICH JOHN W Director Exercise or conversion · Non-Qualified Stock Option (right to buy) −460 0
2013-11-18 Sharp John P VP Finance and CFO Exercise or conversion +624 $9.96 $6K 24,790
2013-11-18 Sharp John P VP Finance and CFO Sale −1,123 $53.00 $60K 23,667
2013-11-18 Sharp John P VP Finance and CFO Exercise or conversion · Non-Qualified Stock Option (right to buy) −624 8,542
2013-10-22 HIGGINS JOHN L President & CEO Exercise or conversion +5,850 $21.00 $123K 112,431
2013-10-22 HIGGINS JOHN L President & CEO Exercise or conversion +4,668 $10.05 $47K 117,099
2013-10-22 HIGGINS JOHN L President & CEO Exercise or conversion · Incentive Stock Option (right to buy) −4,668 15,675
2013-10-22 HIGGINS JOHN L President & CEO Exercise or conversion · Incentive Stock Option (right to buy) −5,850 37,483
2013-10-18 HIGGINS JOHN L President & CEO Sale −10,000 $55.00 $550K 106,581
2013-09-23 BVF PARTNERS L P/IL 10% owner Sale −211,217 $44.50 $9.4M 530,410
2013-09-23 BVF PARTNERS L P/IL 10% owner Sale −147,806 $44.50 $6.6M 296,345
2013-09-12 KNOTT DAVID M Director Sale −160,000 $46.78 $7.5M 51,396
2013-08-30 Berkman Charles S VP, Gen. Counsel & Secretary Exercise or conversion +9,499 $21.00 $199K 27,427

Page 81 of 86 · 1,712 trades